{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:03:27Z","timestamp":1781701407525,"version":"3.54.5"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:00:00Z","timestamp":1556323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s40620-019-00615-0","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T05:03:08Z","timestamp":1556341388000},"page":"709-717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of uric acid in mineral bone disorders in chronic kidney disease"],"prefix":"10.1093","volume":"32","author":[{"given":"Baris","family":"Afsar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A.","family":"Sag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinar","family":"Oztosun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,27]]},"reference":[{"issue":"3","key":"615_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/CS20090631","volume":"119","author":"A Covic","year":"2010","unstructured":"Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL et al (2010) Vascular calcification in chronic kidney disease. Clin Sci (Lond). 119(3):111\u2013121","journal-title":"Clin Sci (Lond)."},{"issue":"6","key":"615_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s11255-016-1240-0","volume":"48","author":"AA Sag","year":"2016","unstructured":"Sag AA, Covic A, London G, Vervloet M, Goldsmith D, Gorriz JL et al (2016) Clinical imaging of vascular disease in chronic kidney disease. Int Urol Nephrol 48(6):827\u2013837","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"615_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000197562","volume":"27","author":"M Kanbay","year":"2009","unstructured":"Kanbay M, Goldsmith D, Akcay A, Covic A (2009) Phosphate\u2014the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review. Blood Purif 27(2):220\u2013230","journal-title":"Blood Purif"},{"key":"615_CR4","doi-asserted-by":"publisher","first-page":"767424","DOI":"10.1155\/2014\/767424","volume":"2014","author":"B Afsar","year":"2014","unstructured":"Afsar B, Turkmen K, Covic A, Kanbay M (2014) An update on coronary artery disease and chronic kidney disease. Int J Nephrol 2014:767424","journal-title":"Int J Nephrol"},{"issue":"10","key":"615_CR5","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.2215\/CJN.02560310","volume":"5","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B et al (2010) Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease. Clin J Am Soc Nephrol 5(10):1780\u20131786","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"615_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00223-016-0206-7","volume":"100","author":"M Kanbay","year":"2017","unstructured":"Kanbay M, Vervloet M, Cozzolino M, Siriopol D, Covic A, Goldsmith D et al (2017) Novel Faces of Fibroblast Growth Factor 23 (FGF23): iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury. Calcif Tissue Int 100(3):217\u2013228","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"615_CR7","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s11255-016-1387-8","volume":"48","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, Solak Y, Siriopol D, Aslan G, Afsar B, Yazici D et al (2016) Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis. Int Urol Nephrol 48(12):2029\u20132042","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"615_CR8","doi-asserted-by":"publisher","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","volume":"99","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H et al (2014) Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients. J Clin Endocrinol Metab 99(10):E1854\u2013E1861","journal-title":"J Clin Endocrinol Metab"},{"key":"615_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","volume":"100","author":"KA Hruska","year":"2017","unstructured":"Hruska KA, Sugatani T, Agapova O, Fang Y (2017) The chronic kidney disease\u2014mineral bone disorder (CKD-MBD): advances in pathophysiology. Bone 100:80\u201386","journal-title":"Bone"},{"issue":"5","key":"615_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jare.2016.09.006","volume":"8","author":"K Hahn","year":"2017","unstructured":"Hahn K, Kanbay M, Lanaspa MA, Johnson RJ, Ejaz AA (2017) Serum uric acid and acute kidney injury: a mini review. J Adv Res. 8(5):529\u2013536","journal-title":"J Adv Res."},{"issue":"1","key":"615_CR11","doi-asserted-by":"publisher","first-page":"11735","DOI":"10.1038\/s41598-018-30267-2","volume":"8","author":"T Jensen","year":"2018","unstructured":"Jensen T, Niwa K, Hisatome I, Kanbay M, Andres-Hernando A, Roncal-Jimenez CA et al (2018) Increased serum uric acid over five years is a risk factor for developing fatty liver. Sci Rep. 8(1):11735","journal-title":"Sci Rep."},{"key":"615_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"M Kanbay","year":"2016","unstructured":"Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C et al (2016) Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med. 29:3\u20138","journal-title":"Eur J Intern Med."},{"issue":"8","key":"615_CR13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1097\/JIM.0000000000000242","volume":"63","author":"M Takir","year":"2015","unstructured":"Takir M, Kostek O, Ozkok A, Elcioglu OC, Bakan A, Erek A et al (2015) Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia. J Investig Med 63(8):924\u2013929","journal-title":"J Investig Med"},{"issue":"4","key":"615_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000324847","volume":"33","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Yilmaz MI, Sonmez A, Turgut F, Saglam M, Cakir E et al (2011) Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease. Am J Nephrol 33(4):298\u2013304","journal-title":"Am J Nephrol"},{"issue":"4","key":"615_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000360609","volume":"39","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Nistor I, Elcioglu OC, Telci O, Takir M et al (2014) Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol 39(4):348\u2013356","journal-title":"Am J Nephrol"},{"issue":"4","key":"615_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000321074","volume":"30","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A (2010) Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif 30(4):288\u2013295","journal-title":"Blood Purif"},{"issue":"9","key":"615_CR17","doi-asserted-by":"publisher","first-page":"e0137449","DOI":"10.1371\/journal.pone.0137449","volume":"10","author":"T Toyama","year":"2015","unstructured":"Toyama T, Furuichi K, Shimizu M, Hara A, Iwata Y, Sakai N et al (2015) Relationship between serum uric acid levels and chronic kidney disease in a japanese cohort with normal or mildly reduced kidney function. PLoS One 10(9):e0137449","journal-title":"PLoS One"},{"issue":"4","key":"615_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000342390","volume":"36","author":"M Kanbay","year":"2012","unstructured":"Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E et al (2012) Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Am J Nephrol 36(4):324\u2013331","journal-title":"Am J Nephrol"},{"issue":"4","key":"615_CR19","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000324916","volume":"33","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Ikizek M, Solak Y, Selcoki Y, Uysal S, Armutcu F et al (2011) Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol 33(4):325\u2013331","journal-title":"Am J Nephrol"},{"issue":"11","key":"615_CR20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/ejhf.419","volume":"17","author":"TG Lueder von","year":"2015","unstructured":"von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M et al (2015) Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the high-risk myocardial infarction database initiative. Eur J Heart Fail 17(11):1144\u20131151","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"615_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jch.12026","volume":"15","author":"O Turak","year":"2013","unstructured":"Turak O, Ozcan F, Tok D, Isleyen A, Sokmen E, Tasoglu I et al (2013) Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. J Clin Hypertens (Greenwich). 15(1):7\u201313","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"12","key":"615_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/jch.12641","volume":"17","author":"K Cagli","year":"2015","unstructured":"Cagli K, Turak O, Canpolat U, Ozcan F, Tok D, Mendi MA et al (2015) Association of serum uric acid level with blood pressure variability in newly diagnosed essential hypertension. J Clin Hypertens (Greenwich). 17(12):929\u2013935","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"3","key":"615_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/HYPERTENSIONAHA.118.11496","volume":"72","author":"M Kuwabara","year":"2018","unstructured":"Kuwabara M, Kanbay M, Hisatome I (2018) Uric acid and hypertension because of arterial stiffness. Hypertension 72(3):582\u2013584","journal-title":"Hypertension"},{"issue":"2","key":"615_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/MNH.0000000000000203","volume":"25","author":"AL Lundquist","year":"2016","unstructured":"Lundquist AL, Nigwekar SU (2016) Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease. Curr Opin Nephrol Hypertens 25(2):120\u2013126","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"615_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u201338","journal-title":"Kidney Int"},{"issue":"12","key":"615_CR26","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79(12):1370\u20131378","journal-title":"Kidney Int"},{"issue":"5","key":"615_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1681\/ASN.2008070783","volume":"20","author":"EG Farrow","year":"2009","unstructured":"Farrow EG, Davis SI, Summers LJ, White KE (2009) Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol 20(5):955\u2013960","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"615_CR28","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/jbmr.170","volume":"25","author":"H Juppner","year":"2010","unstructured":"Juppner H, Wolf M, Salusky IB (2010) FGF-23: more than a regulator of renal phosphate handling? J Bone Miner Res 25(10):2091\u20132097","journal-title":"J Bone Miner Res"},{"issue":"1","key":"615_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrneph.2016.164","volume":"13","author":"MG Vervloet","year":"2017","unstructured":"Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D et al (2017) The role of phosphate in kidney disease. Nat Rev Nephrol. 13(1):27\u201338","journal-title":"Nat Rev Nephrol."},{"issue":"11","key":"615_CR30","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int 69(11):1945\u20131953","journal-title":"Kidney Int"},{"issue":"4","key":"615_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1525-139X.2005.18405.x","volume":"18","author":"WG Goodman","year":"2005","unstructured":"Goodman WG (2005) The evolution of assays for parathyroid hormone. Semin Dial 18(4):296\u2013301","journal-title":"Semin Dial"},{"issue":"2","key":"615_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00000441-200008000-00004","volume":"320","author":"A Ferreira","year":"2000","unstructured":"Ferreira A, Drueke TB (2000) Biological markers in the diagnosis of the different forms of renal osteodystrophy. Am J Med Sci 320(2):85\u201389","journal-title":"Am J Med Sci"},{"key":"615_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","volume":"278","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D\u2019Avino R Jr et al (2018) CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies. Atherosclerosis. 278:49\u201359","journal-title":"Atherosclerosis."},{"issue":"3","key":"615_CR34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11255-009-9675-1","volume":"42","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A (2010) Arterial stiffness in dialysis patients: where are we now? Int Urol Nephrol 42(3):741\u2013752","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"615_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"DD Bikle","year":"2014","unstructured":"Bikle DD (2014) Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 21(3):319\u2013329","journal-title":"Chem Biol"},{"issue":"4","key":"615_CR36","doi-asserted-by":"publisher","first-page":"e61159","DOI":"10.1371\/journal.pone.0061159","volume":"8","author":"H Peng","year":"2013","unstructured":"Peng H, Li H, Li C, Chao X, Zhang Q, Zhang Y (2013) Association between vitamin D insufficiency and elevated serum uric acid among middle-aged and elderly Chinese Han women. PLoS One 8(4):e61159","journal-title":"PLoS One"},{"issue":"1","key":"615_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.dsx.2012.05.007","volume":"6","author":"H Yilmaz","year":"2012","unstructured":"Yilmaz H, Kaya M, Sahin M, Delibasi T (2012) Is vitamin D status a predictor glycaemic regulation and cardiac complication in type 2 diabetes mellitus patients? Diabetes Metab Syndr. 6(1):28\u201331","journal-title":"Diabetes Metab Syndr."},{"issue":"4","key":"615_CR38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.V441035","volume":"4","author":"R Vanholder","year":"1993","unstructured":"Vanholder R, Patel S, Hsu CH (1993) Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure. J Am Soc Nephrol 4(4):1035\u20131038","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"615_CR39","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0026-0495(98)90267-0","volume":"47","author":"S Takahashi","year":"1998","unstructured":"Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Yamakita J, Higashino K (1998) Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout. Metabolism. 47(3):336\u2013338","journal-title":"Metabolism."},{"issue":"4 Pt 2","key":"615_CR40","first-page":"F596","volume":"260","author":"CH Hsu","year":"1991","unstructured":"Hsu CH, Patel SR, Young EW, Vanholder R (1991) Effects of purine derivatives on calcitriol metabolism in rats. Am J Physiol 260(4 Pt 2):F596\u2013F601","journal-title":"Am J Physiol"},{"issue":"1","key":"615_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.metabol.2013.09.018","volume":"63","author":"W Chen","year":"2014","unstructured":"Chen W, Roncal-Jimenez C, Lanaspa M, Gerard S, Chonchol M, Johnson RJ et al (2014) Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism. 63(1):150\u2013160","journal-title":"Metabolism."},{"key":"615_CR42","doi-asserted-by":"publisher","first-page":"14528","DOI":"10.1038\/srep14528","volume":"5","author":"A Thakkinstian","year":"2015","unstructured":"Thakkinstian A, Anothaisintawee T, Chailurkit L, Ratanachaiwong W, Yamwong S, Sritara P et al (2015) Potential causal associations between vitamin D and uric acid: bidirectional mediation analysis. Sci Rep. 5:14528","journal-title":"Sci Rep."},{"key":"615_CR43","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2147\/CIA.S90233","volume":"10","author":"KY Chin","year":"2015","unstructured":"Chin KY, Nirwana SI, Ngah WZ (2015) Significant association between parathyroid hormone and uric acid level in men. Clin Interv Aging 10:1377\u20131380","journal-title":"Clin Interv Aging"},{"issue":"2","key":"615_CR44","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/ar3769","volume":"14","author":"JY Hui","year":"2012","unstructured":"Hui JY, Choi JW, Mount DB, Zhu Y, Zhang Y, Choi HK (2012) The independent association between parathyroid hormone levels and hyperuricemia: a national population study. Arthritis Res Ther. 14(2):R56","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"615_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/met.2015.0099","volume":"14","author":"R Alemzadeh","year":"2016","unstructured":"Alemzadeh R, Kichler J (2016) Uric acid-induced inflammation is mediated by the parathyroid hormone: 25-hydroxyvitamin D ratio in obese adolescents. Metab Syndr Relat Disord. 14(3):167\u2013174","journal-title":"Metab Syndr Relat Disord."},{"issue":"1","key":"615_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00774-005-0647-y","volume":"24","author":"F Saleh","year":"2006","unstructured":"Saleh F, Jorde R, Sundsfjord J, Haug E, Figenschau Y (2006) Causes of secondary hyperparathyroidism in a healthy population: the Tromso study. J Bone Miner Metab 24(1):58\u201364","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"615_CR47","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2169\/internalmedicine.31.807","volume":"31","author":"I Hisatome","year":"1992","unstructured":"Hisatome I, Ishimura M, Sasaki N, Yamakawa M, Kosaka H, Tanaka Y et al (1992) Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism. Intern Med 31(6):807\u2013811","journal-title":"Intern Med"},{"issue":"6","key":"615_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1046\/j.1365-2265.2001.01265.x","volume":"54","author":"J Westerdahl","year":"2001","unstructured":"Westerdahl J, Valdemarsson S, Lindblom P, Bergenfelz A (2001) Urate and arteriosclerosis in primary hyperparathyroidism. Clin Endocrinol (Oxf) 54(6):805\u2013811","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"615_CR49","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00268-007-9091-6","volume":"31","author":"A Bergenfelz","year":"2007","unstructured":"Bergenfelz A, Bladstrom A, Their M, Nordenstrom E, Valdemarsson S, Westerdahl J (2007) Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study. World J Surg. 31(7):1393\u20131400 (discussion 401-2)","journal-title":"World J Surg."},{"issue":"3","key":"615_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1365-2796.1998.00366.x","volume":"244","author":"S Valdemarsson","year":"1998","unstructured":"Valdemarsson S, Lindblom P, Bergenfelz A (1998) Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effects of surgical treatment. J Intern Med 244(3):241\u2013249","journal-title":"J Intern Med"},{"issue":"3","key":"615_CR51","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0009-8981(77)90147-4","volume":"80","author":"T Christensson","year":"1977","unstructured":"Christensson T (1977) Serum urate in subjects with hypercalcaemic hyperparathyroidism. Clin Chim Acta 80(3):529\u2013533","journal-title":"Clin Chim Acta"},{"issue":"2","key":"615_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/rheumatology\/ken416","volume":"48","author":"N Dalbeth","year":"2009","unstructured":"Dalbeth N, Horne A, Gamble GD, Ames R, Mason B, McQueen FM et al (2009) The effect of calcium supplementation on serum urate: analysis of a randomized controlled trial. Rheumatology (Oxford) 48(2):195\u2013197","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"615_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","volume":"18","author":"PD Miller","year":"2007","unstructured":"Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH (2007) Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 18(1):59\u201368","journal-title":"Osteoporos Int"},{"issue":"3","key":"615_CR54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435","journal-title":"J Bone Miner Res"},{"issue":"6","key":"615_CR55","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64(6):2272\u20132279","journal-title":"Kidney Int"},{"issue":"2","key":"615_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","volume":"205","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Lind L, Larsson TE (2009) Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis. 205(2):385\u2013390","journal-title":"Atherosclerosis."},{"issue":"10","key":"615_CR57","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.metabol.2016.07.005","volume":"65","author":"T Sakoh","year":"2016","unstructured":"Sakoh T, Nakayama M, Tsuchihashi T, Yoshitomi R, Tanaka S, Katafuchi E et al (2016) Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease. Metabolism. 65(10):1498\u20131507","journal-title":"Metabolism."},{"issue":"1","key":"615_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.transproceed.2013.10.043","volume":"46","author":"E Asicioglu","year":"2014","unstructured":"Asicioglu E, Kahveci A, Arikan H, Koc M, Tuglular S, Ozener C (2014) Fibroblast growth factor-23 levels are associated with uric acid but not carotid intima media thickness in renal transplant recipients. Transplant Proc. 46(1):180\u2013183","journal-title":"Transplant Proc."},{"issue":"12","key":"615_CR59","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2215\/CJN.02740311","volume":"6","author":"OM Gutierrez","year":"2011","unstructured":"Gutierrez OM, Wolf M, Taylor EN (2011) Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol 6(12):2871\u20132878","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"615_CR60","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1681\/ASN.2009121293","volume":"21","author":"M Wolf","year":"2010","unstructured":"Wolf M (2010) Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 21(9):1427\u20131435","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"615_CR61","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/art.39581","volume":"68","author":"M Andres","year":"2016","unstructured":"Andres M, Quintanilla MA, Sivera F, Sanchez-Paya J, Pascual E, Vela P et al (2016) Silent monosodium urate crystal deposits are associated with severe coronary calcification in asymptomatic hyperuricemia: an exploratory study. Arthritis Rheumatol. 68(6):1531\u20131539","journal-title":"Arthritis Rheumatol."},{"issue":"14","key":"615_CR62","doi-asserted-by":"publisher","first-page":"e6565","DOI":"10.1097\/MD.0000000000006565","volume":"96","author":"H Kim","year":"2017","unstructured":"Kim H, Kim SH, Choi AR, Kim S, Choi HY, Kim HJ et al (2017) Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: a single-center cross-sectional study. Medicine (Baltimore). 96(14):e6565","journal-title":"Medicine (Baltimore)."},{"issue":"7","key":"615_CR63","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/ajh\/hpu253","volume":"28","author":"T Mehta","year":"2015","unstructured":"Mehta T, Nuccio E, McFann K, Madero M, Sarnak MJ, Jalal D (2015) Association of uric acid with vascular stiffness in the framingham heart study. Am J Hypertens 28(7):877\u2013883","journal-title":"Am J Hypertens"},{"issue":"4","key":"615_CR64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1155\/2013\/846059","volume":"34","author":"CT Lee","year":"2013","unstructured":"Lee CT, Chua S, Hsu CY, Tsai YC, Ng HY, Kuo CC et al (2013) Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients. Dis Markers 34(4):229\u2013235","journal-title":"Dis Markers"},{"issue":"10","key":"615_CR65","doi-asserted-by":"publisher","first-page":"e0205831","DOI":"10.1371\/journal.pone.0205831","volume":"13","author":"ES Andrews","year":"2018","unstructured":"Andrews ES, Perrenoud L, Nowak KL, You Z, Pasch A, Chonchol M et al (2018) Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post hoc analysis of a randomized clinical trial. PLoS One 13(10):e0205831","journal-title":"PLoS One"},{"issue":"4","key":"615_CR66","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11255-007-9253-3","volume":"39","author":"M Kanbay","year":"2007","unstructured":"Kanbay M, Ozkara A, Selcoki Y, Isik B, Turgut F, Bavbek N et al (2007) Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions. Int Urol Nephrol 39(4):1227\u20131233","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"615_CR67","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A et al (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5(8):1388\u20131393","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"615_CR68","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2215\/CJN.11451210","volume":"6","author":"M Kanbay","year":"2011","unstructured":"Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I et al (2011) A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 6(8):1887\u20131894","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"615_CR69","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/jbmr.286","volume":"26","author":"I Nabipour","year":"2011","unstructured":"Nabipour I, Sambrook PN, Blyth FM, Janu MR, Waite LM, Naganathan V et al (2011) Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res 26(5):955\u2013964","journal-title":"J Bone Miner Res"},{"issue":"12","key":"615_CR70","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1007\/s00198-013-2377-7","volume":"24","author":"SH Ahn","year":"2013","unstructured":"Ahn SH, Lee SH, Kim BJ, Lim KH, Bae SJ, Kim EH et al (2013) Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporos Int 24(12):2961\u20132970","journal-title":"Osteoporos Int"},{"issue":"10","key":"615_CR71","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.molmed.2009.08.004","volume":"15","author":"F Wauquier","year":"2009","unstructured":"Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y (2009) Oxidative stress in bone remodelling and disease. Trends Mol Med. 15(10):468\u2013477","journal-title":"Trends Mol Med."},{"issue":"3","key":"615_CR72","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","volume":"106","author":"NK Lee","year":"2005","unstructured":"Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS et al (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106(3):852\u2013859","journal-title":"Blood"},{"issue":"4","key":"615_CR73","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1210\/jc.2002-021496","volume":"88","author":"D Maggio","year":"2003","unstructured":"Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P et al (2003) Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88(4):1523\u20131527","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"615_CR74","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bone.2012.10.025","volume":"52","author":"J Makovey","year":"2013","unstructured":"Makovey J, Macara M, Chen JS, Hayward CS, March L, Seibel MJ et al (2013) Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone 52(1):400\u2013406","journal-title":"Bone"},{"issue":"7","key":"615_CR75","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00198-014-2697-2","volume":"25","author":"BJ Kim","year":"2014","unstructured":"Kim BJ, Baek S, Ahn SH, Kim SH, Jo MW, Bae SJ et al (2014) Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: a longitudinal study using the National Claim Registry. Osteoporos Int 25(7):1837\u20131844","journal-title":"Osteoporos Int"},{"key":"615_CR76","doi-asserted-by":"publisher","first-page":"2528956","DOI":"10.1155\/2016\/2528956","volume":"2016","author":"DD Zhao","year":"2016","unstructured":"Zhao DD, Jiao PL, Yu JJ, Wang XJ, Zhao L, Xuan Y et al (2016) Higher serum uric acid is associated with higher bone mineral density in Chinese men with type 2 diabetes mellitus. Int J Endocrinol. 2016:2528956","journal-title":"Int J Endocrinol."},{"issue":"6","key":"615_CR77","first-page":"443","volume":"6","author":"Z Chen","year":"2014","unstructured":"Chen Z, Ding Z, Fu C, Yu C, Ma G (2014) Correlation between serum uric Acid and renal function in patients with stable coronary artery disease and type 2 diabetes. J Clin Med Res. 6(6):443\u2013450","journal-title":"J Clin Med Res."},{"issue":"12","key":"615_CR78","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/ndt\/gfu256","volume":"29","author":"K Kamei","year":"2014","unstructured":"Kamei K, Konta T, Hirayama A, Suzuki K, Ichikawa K, Fujimoto S et al (2014) A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population. Nephrol Dial Transplant 29(12):2286\u20132292","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"615_CR79","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1007\/s00198-017-4221-y","volume":"28","author":"L Malmgren","year":"2017","unstructured":"Malmgren L, McGuigan F, Christensson A, Akesson KE (2017) Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study. Osteoporos Int 28(12):3463\u20133473","journal-title":"Osteoporos Int"},{"issue":"6","key":"615_CR80","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/jbmr.2430","volume":"30","author":"D Zhang","year":"2015","unstructured":"Zhang D, Bobulescu IA, Maalouf NM, Adams-Huet B, Poindexter J, Park S et al (2015) Relationship between serum uric Acid and bone mineral density in the general population and in rats with experimental hyperuricemia. J Bone Miner Res 30(6):992\u2013999","journal-title":"J Bone Miner Res"},{"issue":"3","key":"615_CR81","doi-asserted-by":"publisher","first-page":"342","DOI":"10.11613\/BM.2013.042","volume":"23","author":"M Nybo","year":"2013","unstructured":"Nybo M, Jespersen B, Aarup M, Ejersted C, Hermann AP, Brixen K (2013) Determinants of bone mineral density in patients on haemodialysis or peritoneal dialysis\u2014a cross-sectional, longitudinal study. Biochem Med (Zagreb). 23(3):342\u2013350","journal-title":"Biochem Med (Zagreb)."},{"issue":"5","key":"615_CR82","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jc.2012-4188","volume":"98","author":"MR Denburg","year":"2013","unstructured":"Denburg MR, Tsampalieros AK, de Boer IH, Shults J, Kalkwarf HJ, Zemel BS et al (2013) Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab 98(5):1930\u20131938","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"615_CR83","doi-asserted-by":"publisher","first-page":"485","DOI":"10.5301\/jn.5000185","volume":"26","author":"SH Park","year":"2013","unstructured":"Park SH, Jia T, Qureshi AR, Barany P, Heimburger O, Larsson TE et al (2013) Determinants and survival implications of low bone mineral density in end-stage renal disease patients. J Nephrol. 26(3):485\u2013494","journal-title":"J Nephrol."},{"key":"615_CR84","doi-asserted-by":"crossref","unstructured":"Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Kanbay M, Ortiz A. Potential dangers of serum urate-lowering therapy. Am J Med. 2019","DOI":"10.1016\/j.amjmed.2018.12.010"},{"key":"615_CR85","doi-asserted-by":"crossref","unstructured":"Barreto FC, Costa C, Reis LMD, Custodio MR. Bone biopsy in nephrology practice. J Bras Nefrol. 2018","DOI":"10.1590\/2175-8239-jbn-2017-0012"},{"key":"615_CR86","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.2147\/CIA.S186199","volume":"13","author":"Q Cheng","year":"2018","unstructured":"Cheng Q, Wu X, Du Y, Hong W, Tang W, Li H et al (2018) Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol. Clin Interv Aging 13:2367\u20132374","journal-title":"Clin Interv Aging"},{"issue":"2","key":"615_CR87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"issue":"4","key":"615_CR88","first-page":"37","volume":"4","author":"GE Grieco","year":"2018","unstructured":"Grieco GE, Cataldo D, Ceccarelli E, Nigi L, Catalano G, Brusco N et al (2018) Serum levels of miR-148a and miR-21-5p are increased in Type 1 diabetic patients and correlated with markers of bone strength and metabolism. Noncoding RNA. 4(4):37","journal-title":"Noncoding RNA."},{"issue":"1","key":"615_CR89","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2018.04.138","volume":"501","author":"CJ Yao","year":"2018","unstructured":"Yao CJ, Lv Y, Zhang CJ, Jin JX, Xu LH, Jiang J et al (2018) MicroRNA-185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt\/beta-catenin axis: in an animal experiment. Biochem Biophys Res Commun 501(1):55\u201363","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"615_CR90","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1681\/ASN.2016050585","volume":"28","author":"V Shilo","year":"2017","unstructured":"Shilo V, Mor-Yosef Levi I, Abel R, Mihailovic A, Wasserman G, Naveh-Many T et al (2017) Let-7 and MicroRNA-148 regulate parathyroid hormone levels in secondary hyperparathyroidism. J Am Soc Nephrol 28(8):2353\u20132363","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"615_CR91","doi-asserted-by":"publisher","first-page":"e0170535","DOI":"10.1371\/journal.pone.0170535","volume":"12","author":"S Jeong","year":"2017","unstructured":"Jeong S, Oh JM, Oh KH, Kim IW (2017) Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients. PLoS One 12(2):e0170535","journal-title":"PLoS One"},{"issue":"1","key":"615_CR92","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12020-016-1069-4","volume":"55","author":"Y Shao","year":"2017","unstructured":"Shao Y, Ren H, Lv C, Ma X, Wu C, Wang Q (2017) Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine 55(1):130\u2013138","journal-title":"Endocrine"},{"issue":"6","key":"615_CR93","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jcla.21708","volume":"28","author":"ZM Tang","year":"2014","unstructured":"Tang ZM, Fang M, Wang JP, Cai PC, Wang P, Hu LH (2014) Clinical relevance of plasma miR-21 in new-onset systemic lupus erythematosus patients. J Clin Lab Anal 28(6):446\u2013451","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"615_CR94","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/micc.12200","volume":"22","author":"Q Hong","year":"2015","unstructured":"Hong Q, Yu S, Geng X, Duan L, Zheng W, Fan M et al (2015) High concentrations of uric acid inhibit endothelial cell migration via miR-663 which regulates phosphatase and tensin homolog by targeting transforming growth factor-beta1. Microcirculation. 22(4):306\u2013314","journal-title":"Microcirculation."},{"issue":"11","key":"615_CR95","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1253\/circj.CJ-15-0283","volume":"79","author":"S Yu","year":"2015","unstructured":"Yu S, Hong Q, Wang Y, Hou K, Wang L, Zhang Y et al (2015) High concentrations of uric acid inhibit angiogenesis via regulation of the Kruppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a. Circ J 79(11):2487\u20132498","journal-title":"Circ J"},{"issue":"2","key":"615_CR96","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.156","volume":"88","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, D\u2019Haese P, Brandenburg V (2015) Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88(2):235\u2013240","journal-title":"Kidney Int"},{"issue":"8","key":"615_CR97","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1681\/ASN.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC et al (2014) CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol 25(8):1760\u20131773","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"615_CR98","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.kint.2016.07.039","volume":"91","author":"T Sugatani","year":"2017","unstructured":"Sugatani T, Agapova OA, Fang Y, Berman AG, Wallace JM, Malluche HH et al (2017) Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease. Kidney Int 91(1):86\u201395","journal-title":"Kidney Int"},{"issue":"9","key":"615_CR99","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/ijms19092490","volume":"19","author":"T Sugatani","year":"2018","unstructured":"Sugatani T (2018) Systemic activation of activin a signaling causes chronic kidney disease-mineral bone disorder. Int J Mol Sci. 19(9):2490","journal-title":"Int J Mol Sci."},{"key":"615_CR100","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.exger.2018.07.020","volume":"111","author":"LN Peng","year":"2018","unstructured":"Peng LN, Chou MY, Liang CK, Lee WJ, Kojima T, Lin MH et al (2018) Association between serum activin A and metabolic syndrome in older adults: potential of activin A as a biomarker of cardiometabolic disease. Exp Gerontol 111:197\u2013202","journal-title":"Exp Gerontol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00615-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-019-00615-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00615-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:16Z","timestamp":1777564576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/32\/5\/709\/8328199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,27]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["615"],"URL":"https:\/\/doi.org\/10.1007\/s40620-019-00615-0","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,27]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}